Infection and immunity

Published on 21/03/2015 by admin

Filed under Pediatrics

Last modified 21/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 4627 times

Infection and immunity

Infections are the most common cause of acute illness in children.

Worldwide, acute respiratory infections, diarrhoea, neonatal infection, malaria, measles and HIV infection, often accompanied by undernutrition, are responsible for the deaths of more than 4.5 million children <5 years old annually (Fig. 14.1).

In developed countries, morbidity and mortality from infections has declined dramatically, and deaths from infectious diseases are uncommon. However, serious infections still occur, e.g. meningococcal septicaemia, meningitis, and multi-drug resistant pathogens, and some have re-emerged, e.g. tuberculosis and PVL-toxin-secreting Staphylococcus aureus, and require early recognition and treatment. Children with immune deficiency are vulnerable to a range of unusual or opportunist pathogens.

With air travel, tropical diseases are encountered in all countries. In addition, epidemics may spread widely, e.g. SARS and H1N1, with children (and the elderly) most vulnerable.

The febrile child

Most febrile children have a brief, self-limiting viral infection. Mild localised infections, e.g. otitis media or tonsillitis, may be diagnosed clinically. The clinical problem lies in identifying the relatively few children with a serious infection which needs prompt treatment.

Clinical features

When assessing a febrile child, consider the following.

(ii) How old is the child?

Febrile infants <3 months old present with non-specific clinical features (see Box 10.2) and often have a bacterial infection, which cannot be identified reliably on clinical examination alone. It is uncommon for them to have the common viral infections of older infants and children because of passive immunity from their mothers (Fig. 14.2). Unless a clear cause for the fever is identified, they require urgent investigation with a septic screen (Box 14.1) and intravenous antibiotic therapy given immediately to avoid the illness becoming more severe and to prevent rapid spread to other sites of the body. This is considered in more detail in the section on neonatal infection (Chapter 10 Neonatal medicine).

(vi) Is there a focus for infection?

Examination may identify a focus of infection (Fig. 14.3). If identified, investigations and management will be directed towards its treatment. However, if no focus is identified, this is often because it is the prodromal phase of a viral illness, but may indicate serious bacterial infection, especially urinary tract infection or septicaemia.

Management

Children who are not seriously ill can be managed at home with regular review by the parents, as long as they are given clear instructions (e.g. what clinical features should prompt reassessment by a doctor). Children who are significantly unwell, particularly if there is no focus of infection, will require investigations and observation or treatment in a paediatric assessment unit or A&E department or children’s ward. A septic screen will be required (Box 14.1).

Parenteral antibiotics are given immediately to seriously unwell children, e.g. a third-generation cephalosporin such as cefotaxime or ceftriaxone if >3 months old. In infants 1–3 months old, cefotaxime (in case of septicaemia or meningitis) and ampicillin (in case of Listeria infection) are usually given. Aciclovir is given if herpes simplex encephalitis is suspected. Supportive care is given as indicated.

The child should not be underdressed. The use of antipyretic agents should be considered in children with fever who appear distressed or unwell. They should not be given if the child is otherwise well. Either paracetamol or ibuprofen can be used. They can be given alternatively if unresponsive to a single agent. Evidence that antipyretics prevent febrile seizures is lacking. There are NICE guidelines for the management of the child with fever.

Serious life-threatening infections

Septicaemia

This is considered in Chapter 6 on Paediatric Emergencies.

Meningitis

Meningitis occurs when there is inflammation of the meninges covering the brain. This can be confirmed by finding inflammatory cells in the cerebrospinal fluid (CSF). Viral infections are the most common cause of meningitis, and most are self-resolving. Bacterial meningitis may have severe consequences. Other causes of non-infectious meningitis include malignancy and autoimmune diseases.

Bacterial meningitis

Over 80% of patients with bacterial meningitis in the UK are younger than 16 years old. Bacterial meningitis remains a serious infection in children, with a 5–10% mortality. Over 10% of survivors are left with long-term neurological impairment.

Organisms

The organisms which commonly cause bacterial meningitis vary according to the child’s age (Table 14.1).

Table 14.1

Organisms causing bacterial meningitis according to age

Neonatal–3 months Group B streptococcus
E. coli and other coliforms
Listeria monocytogenes
1 month–6 years Neisseria meningitidis
Streptococcus pneumoniae
Haemophilus influenzae
>6 years Neisseria meningitidis
Streptococcus pneumoniae

image

Presentation

The clinical features are listed in Figure 14.4. The early signs and symptoms of meningitis are non-specific, especially in infants and young children. Only children old enough to talk are likely to describe the classical meningitis symptoms of headache, neck stiffness and photophobia. But neck stiffness may also be seen in some children with tonsillitis and cervical lymphadenopathy. As children with meningitis may also be septicaemic, signs of shock, such as tachycardia, tachypnoea, prolonged capillary refill time, and hypotension, should be sought. Purpura in a febrile child of any age should be assumed to be due to meningococcal sepsis, even if the child does not appear unduly ill at the time; meningitis may or may not be present.

Investigations

The essential investigations are listed in Figure 14.4. A lumbar puncture is performed to obtain CSF to confirm the diagnosis, identify the organism responsible, and its antibiotic sensitivity. If any of the contraindications listed in Figure 14.4 are present, a lumbar puncture should not be performed, as under these circumstances, the procedure carries a risk of coning of the cerebellum through the foramen magnum. In these circumstances, a lumbar puncture can be postponed until the child’s condition has stabilised. Even without a lumbar puncture, bacteriological diagnosis can be achieved in at least 50% of cases from the blood by culture or polymerase chain reaction (PCR), and rapid antigen screens can be performed on blood and urine samples. Throat swabs should also be obtained for bacterial and viral cultures. A serological diagnosis can be made on convalescent serum 4–6 weeks after the presenting illness if necessary.

Cerebral complications

These include:

• Hearing loss. Inflammatory damage to the cochlear hair cells may lead to deafness. All children who have had meningitis should have an audiological assessment promptly, as children who become deaf may benefit from hearing amplification or a cochlear implant.

• Local vasculitis. This may lead to cranial nerve palsies or other focal lesions.

• Local cerebral infarction. This may result in focal or multifocal seizures, which may subsequently lead to epilepsy.

• Subdural effusion. Particularly associated with Haemophilus influenzae and pneumococcal meningitis. This is confirmed by CT scan. Most resolve spontaneously but may require prolonged antibiotic treatment.

• Hydrocephalus. May result from impaired resorption of CSF (communicating hydrocephalus) or blockage of the ventricular outlets by fibrin (non-communicating hydrocephalus). A ventricular shunt may be required.

• Cerebral abscess. The child’s clinical condition deteriorates with the emergence of signs of a space-occupying lesion. The temperature will continue to fluctuate. It is confirmed on CT scan. Drainage of the abscess is required.

Encephalitis/encephalopathy

Whereas in meningitis there is inflammation of the meninges, in encephalitis there is inflammation of the brain substance, although the meninges are often also affected. Encephalitis may be caused by:

In encephalopathy from a non-infectious cause, such as a metabolic abnormality, the clinical features may be similar to an infectious encephalitis.

The clinical features and investigation of encephalitis are described in Figure 14.4. Most children present with fever, altered consciousness and often seizures. Initially, it may not be possible to clinically differentiate encephalitis from meningitis, and treatment for both should be started. The underlying causative organism is only detected in 50% of cases. In the UK, the most frequent causes of encephalitis are enteroviruses, respiratory viruses and herpesviruses (e.g. herpes simplex virus, varicella and HHV6). Worldwide, microorganisms causing encephalitis include Mycoplasma, Borrelia burgdorferi (Lyme disease), Bartonella henselae (cat scratch disease), rickettsial infections (e.g. Rocky Mountain spotted fever) and the arboviruses.

Herpes simplex virus (HSV) is a rare cause of childhood encephalitis but it may have devastating long-term consequences. All children with encephalitis should therefore be treated initially with high-dose intravenous aciclovir, since this is a very safe treatment. Most affected children do not have outward signs of herpes infection, such as cold sores, gingivostomatitis or skin lesions. The PCR of the CSF may be positive for HSV. As HSV encephalitis is a destructive infection, the EEG and CT/MRI scan may show focal changes, particularly within the temporal lobes (Fig. 14.5). These tests may be normal initially and need to be repeated after a few days if the child is not improving. Later confirmation of the diagnosis may be made from HSV antibody production in the CSF. Proven cases of HSV encephalitis or cases where there is a high index of suspicion should be treated with intravenous aciclovir for 3 weeks, as relapses may occur after shorter courses. Untreated, the mortality rate from HSV encephalitis is over 70% and survivors usually have severe neurological sequelae.

Toxic shock syndrome

Toxin-producing Staphylococcus aureus and group A streptococci can cause this syndrome, which is characterised by:

The toxin can be released from infection at any site, including small abrasions or burns, which may look minor. The toxin acts as a superantigen and, in addition to the features above, causes organ dysfunction, including:

Intensive care support is required to manage the shock. Areas of infection should be surgically debrided. Antibiotics often include a third-generation cephalosporin (such as ceftriaxone) together with clindamycin, which acts on the bacterial ribosome to switch off toxin production. Intravenous immunoglobulin may be given to neutralise circulating toxin. About 1–2 weeks after the onset of the illness, there is desquamation of the palms, soles, fingers and toes.

PVL-producing Staphylococcus aureus causes recurrent skin and soft tissue infections, but can also cause necrotising fasciitis and a necrotising haemorrhagic pneumonia following an influenza-like illness; they carry a high mortality. PVL-producing Staphylococcus aureus produces a toxin called Panton-Valentine leukocidin (PVL) which has emerged in the UK and other countries. PVL is produced by fewer than 2% of Staphylococcus aureus strains (both methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA)). In children, the procoagulant state frequently results in venous thrombosis.

Necrotising fasciitis/cellulitis

This is a severe subcutaneous infection, often involving tissue planes from the skin down to fascia and muscle. The area involved may enlarge rapidly, leaving poorly perfused necrotic areas of tissue, usually at the centre. There is severe pain and systemic illness, which may require intensive care. The invading organism may be Staphylococcus aureus or a group A streptococcus, with or without another synergistic anaerobic organism. Intravenous antibiotic therapy alone is not sufficient to treat this condition. Without surgical intervention and debridement of necrotic tissue, the infection will continue to spread. Clinical suspicion of necrotising fasciitis warrants urgent surgical consultation and intervention. Intravenous immunoglobulin (IVIG) may also be given.

Specific bacterial infections

Meningococcal infection

Meningococcal infection is a disease that strikes fear into both parents and doctors, as it can kill previously healthy children within hours (Case History 14.1). However, of the three main causes of bacterial meningitis, meningococcal has the lowest risk of long-term neurological sequelae, with most survivors recovering fully. The septicaemia is usually accompanied by a purpuric rash which may start anywhere on the body and then spread. The rash may or may not be present with meningococcal meningitis. Characteristic lesions are non-blanching on palpation, irregular in size and outline and have a necrotic centre (Fig. 14.8a,b). Any febrile child who develops a purpuric rash should be treated immediately, at home or in the general practitioner’s surgery, with systemic antibiotics such as penicillin before urgent admission to hospital. Although there are now polysaccharide conjugate vaccines against groups A and C meningococcus, there is still no effective vaccine for group B meningococcus, which accounts for the majority of isolates in the UK.

Pneumococcal infections

Streptococcus pneumoniae is often carried in the nasopharynx of healthy children. Asymptomatic carriage is particularly prevalent among young children and may be responsible for the transmission of pneumococcal disease to other individuals by respiratory droplets. The organism may cause pharyngitis, otitis media, conjunctivitis, sinusitis as well as ‘invasive’ disease (pneumonia, bacterial sepsis and meningitis). Invasive disease, which carries a high burden of morbidity and mortality, mainly occurs in young infants as their immune system responds poorly to encapsulated pathogens such as pneumococcus. With the inclusion of the 13-valent pneumococcal vaccine into the standard immunisation schedule in the UK, the incidence of invasive disease has declined. Children at increased risk, e.g. from hyposplenism, should also be given daily prophylactic penicillin to prevent infection by strains not covered by the vaccine.

Staphylococcal and group A streptococcal infections

Staphylococcal and streptococcal infections are usually caused by direct invasion of the organisms. They may also cause disease by releasing toxins which act as superantigens. Whereas conventional antigens stimulate only a small subset of T cells which have a specific receptor, superantigens bind to a part of the T-cell receptor which is shared by many T cells and therefore stimulates massive T-cell proliferation and cytokine release. Other diseases following staphylococcal and streptococcal infections are immune-mediated.

Impetigo

This is a localised, highly contagious, staphylococcal and/or streptococcal skin infection, most common in infants and young children. It is more common where there is pre-existing skin disease, e.g. atopic eczema. Lesions are usually on the face, neck and hands and begin as erythematous macules which may become vesicular/pustular or even bullous (Fig. 14.9). Rupture of the vesicles with exudation of fluid leads to the characteristic confluent honey-coloured crusted lesions. Infection is readily spread to adjacent areas and other parts of the body by autoinoculation of the infected exudate. Topical antibiotics (e.g. mupirocin) are sometimes effective for mild cases. Narrow-spectrum systemic antibiotics (e.g. flucloxacillin) are needed for more severe infections, although more broad-spectrum antibiotics such as co-amoxiclav or cefaclor have simpler oral administration regimens, taste better and therefore have better adherence. Affected children should not go to nursery or school until the lesions are dry. Nasal carriage is an important source of infection which can be eradicated with a nasal cream containing mupirocin or chlorhexidine and neomycin.

Periorbital cellulitis

In periorbital cellulitis there is fever with erythema, tenderness and oedema of the eyelid (Fig. 14.10). It is almost always unilateral. In young, unimmunised children it may also be caused by Haemophilus influenzae type b which may also be accompanied by infection at other sites, e.g. meningitis. It may follow local trauma to the skin. In older children, it may spread from a paranasal sinus infection or dental abscess. Periorbital cellulitis should be treated promptly with intravenous antibiotics to prevent posterior spread of the infection to become an orbital cellulitis. In orbital cellulitis, there is proptosis, painful or limited ocular movement and reduced visual acuity. It may be complicated by abscess formation, meningitis or cavernous sinus thrombosis. Where orbital cellulitis is suspected, a CT scan should be performed to assess the posterior spread of infection and a lumbar puncture may be required to exclude meningitis.

Scalded skin syndrome

This is caused by an exfoliative staphylococcal toxin which causes separation of the epidermal skin through the granular cell layers. It affects infants and young children, who develop fever and malaise and may have a purulent, crusting, localised infection around the eyes, nose and mouth with subsequent widespread erythema and tenderness of the skin. Areas of epidermis separate on gentle pressure (Nikolsky sign), leaving denuded areas of skin (Fig. 14.11), which subsequently dry and heal without scarring. Management is with an intravenous anti-staphylococcal antibiotic, analgesia and monitoring of fluid balance.